Target Information

General Information of This Target (ID: PATR0NRQPL)
Target Name
Glycylpeptide N-tetradecanoyltransferase 1 (NMT1)
Gene Name
NMT1
Gene ID
4836
Synonym
Myristoyl-CoA:protein N-myristoyltransferase 1; Peptide N-myristoyltransferase 1; Protein-lysine myristoyltransferase NMT1
Sequence
MADESETAVKPPAPPLPQMMEGNGNGHEHCSDCENEEDNSYNRGGLSPANDTGAKKKKKK
QKKKKEKGSETDSAQDQPVKMNSLPAERIQEIQKAIELFSVGQGPAKTMEEASKRSYQFW
DTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGVLKELYTLLNENY
VEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISAIPANIHIYDTEK
KMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLPKPVGTCRYWHRS
LNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPVVHQLLTRYLKQF
HLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIMNHPTHKSLKAAY
SFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYN
WKCPSMGAEKVGLVLQ

    Click to Show/Hide
Family
the NMT family
Function
Adds a myristoyl group to the N-terminal glycine residue of certain cellular and viral proteins. Also able to mediate N-terminal lysine myristoylation of proteins: catalyzes myristoylation of ARF6 on both 'Gly-2' and 'Lys-3'. Lysine myristoylation is required to maintain ARF6 on membranes during the GTPase cycle.

    Click to Show/Hide
Uniprot Entry
NMT1_HUMAN
HGNC ID
HGNC:7857
KEGG ID
hsa:4836
Full List of The ADC Related to This Target
Investigative
Click To Hide/Show 1 ADC Related to This Stage
ADC Name Antibody Antigen Payload Linker ADC Info
MYX2449 [1]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
N-Myristolytransferase inhibitor (NMTi)
Undisclosed
ADC Info
Investigative
Click To Hide/Show 7 ADC Related to This Stage
ADC Name Antibody Antigen Payload Linker ADC Info
ZA202500415A-ADC Example 1 [2]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NMT inhibitor 1
ZA202500415A-ADC-Example-1-Linker
ADC Info
ZA202500415A-ADC Example 2 [2]
Rituximab
B-lymphocyte antigen CD20 (MS4A1)
NMT inhibitor 1
ZA202500415A-ADC-Example-1-Linker
ADC Info
ZA202500415A-ADC Example 3 [2]
Sacituzumab
Tumor-associated calcium signal transducer 2 (TACSTD2)
NMT inhibitor 1
ZA202500415A-ADC-Example-1-Linker
ADC Info
ZA202500415A-ADC Example 4 [2]
Ifinatamab
CD276 antigen (CD276)
NMT inhibitor 1
ZA202500415A-ADC-Example-1-Linker
ADC Info
ZA202500415A-ADC Example 5 [2]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NMT inhibitor 26
ZA202500415A-ADC-Example-1-Linker
ADC Info
ZA202500415A-ADC Example 6 [2]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
ZA202500415A-ADC-Example-6-payload
ZA202500415A-ADC-Example-1-Linker
ADC Info
ZA202500415A-ADC Example 7 [2]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NMT inhibitor 1
Mc-Gly-Gly-Phe-Gly
ADC Info
References
Ref 1 N-Myristolytransferase (NMT) inhibitors as novel potent payloads for antibody drug conjugates. Cancer Res (2023) 83 (7_Supplement): 2635.
Ref 2 Antibody drug conjugate comprising NMT inhibitor and its use